ENX-105

N/A

Report date: 2023/06/15 16:52:27
NME

Base Information

Drug NameENX-105
Drug Alias NameENX-105
ClassificationSmall molecules
Mechanisms of ActionDopamine D2 receptor antagonistsDopamine D3 receptor antagonistsDopamine D4 receptor agonists +[5] 
TargetsDopamine D2 receptorDopamine D3 receptorDopamine D4 receptor +[5] 
Therapy Area/IndicationsStress Disorders, Post-TraumaticMood Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEngrail Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEngrail Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsStress Disorders, Post-TraumaticMood Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A